Skip to main content

In this Issue

  • DivaCup makers tout safety, eco-friendliness

    While tampons and menstrual cups have coexisted on the market for decades, presently there is a movement toward the use of menstrual cups, such as Diva International’s DivaCup. According to Research and Markets, the global menstrual cups market is projected to grow at a CAGR of 4% between 2016 and 2020.

    (To view the full OTC Women's Health Report, click here.)

  • 7 ideas for 10X growth

    Transformation happens NOT when something new begins but when something old falls apart. Transformation occurs through the process of letting go of the old and embracing the new, including a reorientation, said philosopher Richard Rohr.

    The transformative companies are growing at a rate at least 10 times the pace of their competitors. What’s their philosophy and what makes them special?

  • Veru’s new female condom measures up

    The Female Health Company, now known as Veru Healthcare following its merger with Aspen Park Pharmaceuticals, earlier this year introduced its Female Condom, FC2, at both Walgreens and Kinney Drugs, and the company is preparing a significant launch into the retail pharmacy space in the new year.

    (To view the full OTC Women's Health Report, click here.)

  • Nutrition segment dominates fall breakthrough brands

    There are definitely several themes playing out across Drug Store News’ top 10 list of breakthrough brands, defined by those brands that have contributed the most impactful growth over an annualized period, in this case for the 52 weeks ended Oct. 2 across total U.S. multi-outlets, according to IRI.

    (To view the full OTC Trend Report, click here.)

  • As approvals roll in, barriers to biosimilars, competition remain

    In its 2016 report on generics savings for the Generic Pharmaceutical Assocation, Quintiles IMS included a snapshot on one of the quickly burgeoning fields of more affordable medicine, biosimilars. Currently, biosimilars are expected to save the healthcare system between $44 billion and $250 billion in the next 10 years.

    (To view the full Category Review, click here.)

  • Disease still prevalent despite ebbing diagnoses

    Even though the number of new diagnoses each year is trending down, diabetes is still a prevalent chronic disease in the United States.

    (To view the full Diabetes Report, click here.)

  • Leveraging service to enhance shopping experience

    Frustrated watching specialty stores, online merchants and department stores siphon off a market they once controlled more than 50% of, mass marketers are firing back.

    (To view the full Category Review, click here.)

    To regain their dominance of the $16 billion U.S. beauty market, chains such as Walgreens, Target, CVS and Walmart are burnishing their images. Among the moves they are taking are:

  • CVS, YMCA partnership curbs new cases

    CVS Health in September partnered with the YMCA to help expand its Diabetes Prevention Program.

    (To view the full Diabetes Report, click here.)

    The YMCA’s Diabetes Prevention Program is a group-based lifestyle intervention for adults at high risk of developing Type 2 diabetes. Through a 12-month, evidence-based plan, the program has been successful in reducing the number of new cases of diabetes by 58% overall and by 71% in adults older than 60 years.

X
This ad will auto-close in 10 seconds